Potential and development of cellular vesicle vaccines in cancer immunotherapy
Abstract Cancer vaccines are promising as an effective means of stimulating the immune system to clear tumors as well as to establish immune surveillance. In this paper, we discuss the main platforms and current status of cancer vaccines and propose a new cancer vaccine platform, the cytosolic vesic...
Saved in:
Main Authors: | Wenxi Zhao, Xianjun Li, Jialu Guan, Shuai Yan, Lizhi Teng, Xitong Sun, Yuhan Dong, Hongyue Wang, Weiyang Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-025-01781-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01) -
Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination
by: Maaweya Awadalla, et al.
Published: (2025-01-01) -
Recent advances in bacterial outer membrane vesicles: Effects on the immune system, mechanisms and their usage for tumor treatment
by: Shuo Xiang, et al.
Published: (2024-12-01) -
Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
by: Florencia Muñoz González, et al.
Published: (2025-01-01) -
Corrigendum: Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
by: Florencia Muñoz González, et al.
Published: (2025-02-01)